Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yang-Hong Dai

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Biomedicines|July 27, 2022
Novel Inflammasome-Based Risk Score for Predicting Survival and Efficacy to Immunotherapy in Early-Stage Non-Small Cell Lung CancerChih-Cheng Tsao, Hsin-Hung Wu, Ying-Fu Wang, et al.
Radiation Oncology (London, England)|October 24, 2019
Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysisJen-Fu Yang, Cheng-Hsiang Lo, Meei-Shyuan Lee, et al.
BMC Cancer|August 22, 2021
Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast CancerYang-Hong Dai, Ying-Fu Wang, Po-Chien Shen, et al.
NPJ Genomic Medicine|June 3, 2021
Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapyYang-Hong Dai, Ying-Fu Wang, Po-Chien Shen, et al.
Environmental Science and Pollution Research International|May 9, 2020
Preparation of aluminum sludge composite gel spheres and adsorption of U(IV) from aqueous solutionJin-Hui Yang, Zeng-Jiang Lei, Yang-Hong Dai, et al.
Japanese Journal of Clinical Oncology|May 9, 2022
Developing a novel DNA methylation risk score for survival and identification of prognostic gene mutations in endometrial cancer: a study based on TCGA dataPo-Chien Shen, Ying-Fu Wang, Hao-Chih Chang, et al.
Biomedicines|March 25, 2022
Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body RadiotherapyPo-Chien Shen, Wen-Yen Huang, Yang-Hong Dai, et al.
JCO Precision Oncology|December 5, 2024
Identification of a Suitable Subgroup for Radiation Dose Escalation in Definitive Concurrent Chemoradiation Therapy for Nonmetastatic Esophageal Squamous Cell CarcinomaPo-Chien Shen, Wei-Kai Chuang, Yang-Hong Dai, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular CarcinomaPo-Chien Shen, Wei-Chou Chang, Cheng-Hsiang Lo, et al.
Radiation Oncology (London, England)|January 15, 2021
Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case seriesYing-Fu Wang, Yang-Hong Dai, Chun-Shu Lin, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Biomedicines|July 27, 2022
Novel Inflammasome-Based Risk Score for Predicting Survival and Efficacy to Immunotherapy in Early-Stage Non-Small Cell Lung CancerChih-Cheng Tsao, Hsin-Hung Wu, Ying-Fu Wang, et al.
Radiation Oncology (London, England)|October 24, 2019
Stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the treatment of hepatocellular carcinoma with portal vein invasion: a retrospective analysisJen-Fu Yang, Cheng-Hsiang Lo, Meei-Shyuan Lee, et al.
BMC Cancer|August 22, 2021
Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast CancerYang-Hong Dai, Ying-Fu Wang, Po-Chien Shen, et al.
NPJ Genomic Medicine|June 3, 2021
Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapyYang-Hong Dai, Ying-Fu Wang, Po-Chien Shen, et al.
Environmental Science and Pollution Research International|May 9, 2020
Preparation of aluminum sludge composite gel spheres and adsorption of U(IV) from aqueous solutionJin-Hui Yang, Zeng-Jiang Lei, Yang-Hong Dai, et al.
Japanese Journal of Clinical Oncology|May 9, 2022
Developing a novel DNA methylation risk score for survival and identification of prognostic gene mutations in endometrial cancer: a study based on TCGA dataPo-Chien Shen, Ying-Fu Wang, Hao-Chih Chang, et al.
Biomedicines|March 25, 2022
Radiomics-Based Predictive Model of Radiation-Induced Liver Disease in Hepatocellular Carcinoma Patients Receiving Stereo-Tactic Body RadiotherapyPo-Chien Shen, Wen-Yen Huang, Yang-Hong Dai, et al.
JCO Precision Oncology|December 5, 2024
Identification of a Suitable Subgroup for Radiation Dose Escalation in Definitive Concurrent Chemoradiation Therapy for Nonmetastatic Esophageal Squamous Cell CarcinomaPo-Chien Shen, Wei-Kai Chuang, Yang-Hong Dai, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular CarcinomaPo-Chien Shen, Wei-Chou Chang, Cheng-Hsiang Lo, et al.
Radiation Oncology (London, England)|January 15, 2021
Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case seriesYing-Fu Wang, Yang-Hong Dai, Chun-Shu Lin, et al.
Pageof 3